SBI Securities’s SANGRIX INC. Class A Ordinary Shares SGRX Stock Holding History

SBI Securities’s Portfolio SGRX Stock Details SGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$214	Buy	34 +28	+467%	+$278	﹤0.01%	3307
2026 Q1	$63	Sell	6 -7	-54%	-$150	﹤0.01%	3527
2025 Q4	$654	Hold	13	–	–	﹤0.01%	2779
2025 Q3	$1.48K	Sell	13 -5	-28%	-$619	﹤0.01%	2540
2025 Q2	$855	Buy	18 +4	+29%	+$195	﹤0.01%	2750
2025 Q1	$825	Buy	14 +13	+1,300%	+$1.88K	﹤0.01%	2662
2024 Q4	$215	Buy	+1	New	+$482	﹤0.01%	3212

Other funds holding SGRX

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CFP

Comprehensive Financial Planning East Petersburg, Pennsylvania $188M AUM 48.26% 1-Year Est. Return

SBI Securities's SGRX Position: Q2 2026 in Review

SBI Securities increased its SANGRIX INC. Class A Ordinary Shares (SGRX) stake by 467% in Q2 2026, buying an estimated $278 and bringing the position to 34 shares worth $214. The position accounts for ﹤0.01% of the portfolio, ranked #3307.

SBI Securities first reported a position in SGRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.48K in Q3 2025. 5 funds tracked by Wall St. Rank hold SGRX as of Q2 2026.

SBI Securities held 34 shares of SANGRIX INC. Class A Ordinary Shares worth $214 as of Q2 2026.
SBI Securities bought 28 SANGRIX INC. Class A Ordinary Shares shares in Q2 2026, an estimated $278.
SANGRIX INC. Class A Ordinary Shares made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3307 holding.
SBI Securities first reported a position in SANGRIX INC. Class A Ordinary Shares in Q4 2024 and has held it in 7 quarters since.
SBI Securities's SANGRIX INC. Class A Ordinary Shares position peaked at $1.48K in Q3 2025.
5 funds tracked by Wall St. Rank held SANGRIX INC. Class A Ordinary Shares as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.